Table: marine pharmacognosy
[['clinical status', 'compound name', 'trademark', 'marine organism α', 'chemical class', 'molecular target', 'clinical trials β', 'disease area'], ['fda - approved', 'cytarabine (ara - c)', 'cytosar - u ®', 'sponge', 'nucleoside', 'dna polymerase', '>50 / 711', 'cancer'], ['fda - approved', 'vidarabine (ara - a)', 'vira - a ®', 'sponge', 'nucleoside', 'viral dna polymerase', '0', 'antiviral'], ['fda - approved', 'ziconotide', 'prialt ®', 'cone snail', 'peptide', 'n - type ca 2 + channel', '2 / 5', 'analgesic'], ['fda - approved', 'eribulin mesylate (e7389)', 'halaven ®', 'sponge', 'macrolide', 's microtubule', '19 / 27', 'cancer'], ['fda - approved', 'omega - 3 - fatty acid ethyl esters', 'lovaza ®', 'fish', 'omega - 3 fatty acids', 'triglyceride - synthesizing enzymes', '45 / 94', 'hypertriglyceridemia'], ['fda - approved', 'trabectedin (et - 743) eu approved only', 'yondelis ®', 'tunicate', 'alkaloid', 'minor groove of dna', '17 / 34', 'cancer'], ['phase iii', 'brentuximab vedotin (sgn - 35)', 'adcetris ®', 'mollusk', 'antibody - drug conjugate (mm auristatin e)', 'cd30 and microtubules', '9 / 19', 'cancer'], ['phase iii', 'plitidepsin', 'aplidin ®', 'tunicate', 'depsipeptide', 'rac1 and jnk activation', '1 / 7', 'cancer'], ['phase ii', 'dmxba (gts - 21)', 'n / a', 'worm', 'alkaloid', 'alpha - 7 nicotinic acetylcholine receptor', '0 / 3', 'congnition , schizophrenia'], ['phase ii', 'plinabulin (npi 2358)', 'n / a', 'fungus', 'diketopiperazine', 'microtubules and jnk stress protein', '1 / 2', 'cancer'], ['phase ii', 'elisidepsin', 'irvalec ®', 'mollusk', 'depsipeptide', 'plasma membrane fluidity', '1 / 2', 'cancer'], ['phase ii', 'pm00104', 'zalypsis ®', 'nudibranch', 'alkaloid', 'dna - binding', '2 / 3', 'cancer'], ['phase ii', 'glembatumumab vedotin (cdx - 011)', 'n / a', 'mollusk', 'antibody drug conjugate (mm auristatin e)', 'glycoprotein nmb and microtubules', '1 / 3', 'cancer'], ['phase i', 'marizomib (salinosporamide a)', 'n / a', 'bacterium', 'beta - lactone - gamma lactam', '20s proteasome', '4 / 4', 'cancer'], ['phase i', 'pm01183', 'n / a', 'tunicate', 'alkaloid', 'minor groove of dna', 'n / a', 'cancer'], ['phase i', 'sgn - 75', 'n / a', 'mollusk', 'antibody drug conjugate (mm auristatin f)', 'cd70 and microtubules', '2 / 2', 'cancer'], ['phase i', 'asg - 5 me', 'n / a', 'mollusk', 'antibody drug conjugate (mm auristatin e)', 'asg - 5 and microtubules', '2 / 2', 'cancer'], ['phase i', 'hemiasterlin (e7974)', 'n / a', 'sponge', 'tripeptide', 'microtubules', '0 / 3', 'cancer'], ['phase i', 'bryostatin 1', 'n / a', 'bryozoa', 'polyketide', 'protein kinase c', '0 / 38', 'cancer , alzheimers'], ['phase i', 's pseudopterosin', 'n / a', 'soft coral', 'diterpene glycoside', 'eicosanoid metabolism', 'n / a', 'wound healing']]
Statement: Tunicate , Nudibranch and Mollusk contain Alkaloid used to treat Cancer
Statement: the Fda has Approved a Chemical Compound in Fish and 1 in Cone Snail that act as an Analgesic
Statement: the Chemical Compound in Fish is for Omega 3 Fatty Acid , the 1 in Cone snails act as an Analgesic
Statement: Tunicate contains the Compound Trabectedin as well as the Compound Pm01183
Statement: Sponge contain the Chemical Class Nucleoside and Macrolide , which are used in the treatment of Cancer